We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medtronic Eyes Drug-Eluting Stent Market; Files PMA for Endeavor
Medtronic Eyes Drug-Eluting Stent Market; Files PMA for Endeavor
November 3, 2005
Medtronic has submitted a premarket approval (PMA) module to the FDA for its Endeavor drug-eluting stent — a move that brings the large devicemaker closer to entering the lucrative U.S. drug-coated stent market.